A multicenter, placebo controlled, randomized, double blind, subject initiated study of the safety and efficacy of the electrokinetic transdermal system (ETS) with acyclovir gel for the episodic treatment of herpes labialis

Trial Profile

A multicenter, placebo controlled, randomized, double blind, subject initiated study of the safety and efficacy of the electrokinetic transdermal system (ETS) with acyclovir gel for the episodic treatment of herpes labialis

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Feb 2008

At a glance

  • Drugs Aciclovir (Primary)
  • Indications Herpes labialis
  • Focus Therapeutic Use
  • Sponsors Transport Pharmaceuticals
  • Most Recent Events

    • 01 Feb 2008 Status change from in progress to completed as reported by clinicaltrials.gov.
    • 27 Aug 2007 Status changed from recruiting to in progress.
    • 12 Feb 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top